State of the art: Using natriuretic peptide levels in clinical practice
-
- Alan Maisel
- VA San Diego Healthcare System United States
-
- Christian Mueller
- University Hospital Basel Switzerland
-
- Kirkwood Adams
- University of North Carolina Chapel Hill United States
-
- Stefan D. Anker
- Charite, Campus Virchow‐Klinikum Berlin Germany
-
- Nadia Aspromonte
- San Spirito Hospital Rome Italy
-
- John G.F. Cleland
- Castle Hill Hospital, University of Hull Kingston‐upon‐Hull UK
-
- Alain Cohen‐Solal
- Hopital Lariboisiere Paris France
-
- Ulf Dahlstrom
- Linkoping University Hospital Linkoping Sweden
-
- Anthony DeMaria
- University of California San Diego United States
-
- Salvatore Di Somma
- Sant'Andrea Hospital University La Sapienza Rome Italy
-
- Gerasimos S. Filippatos
- Athens University Hospital Attikon Athens Greece
-
- Gregg C. Fonarow
- University of California Los Angeles United States
-
- Patrick Jourdain
- Paris Descartes University Paris France
-
- Michel Komajda
- Department of Cardiology, Pitie Salpetriere Hospital University Pierre & Marie Curie, Paris 6 Paris France
-
- Peter P. Liu
- University of Toronto Canada
-
- Theresa McDonagh
- Royal Brompton Hospital London UK
-
- Kenneth McDonald
- St. Vincents University Hospital Dublin Ireland
-
- Alexandre Mebazaa
- University Paris 7 Diderot, Hopital Lariboisiere Paris France
-
- Markku S. Nieminen
- Helsinki University Central Hospital Helsinki Finland
-
- W. Frank Peacock
- The Cleveland Clinic Cleveland Ohio United States
-
- Marco Tubaro
- San Filippo Neri Hospital Rome Italy
-
- Roberto Valle
- Centro per lo Scompenso Ospedale Civile San Dona di Piave Italy
-
- Marc Vanderhyden
- Onze Lieve Vrouwe Ziekenhuis Aalst Belgium
-
- Clyde W. Yancy
- Baylor University Medical Center Dallas Texas United States
-
- Faiez Zannad
- Inserm Centre d'Investigation Cliniques Nancy France
-
- Eugene Braunwald
- Brigham and Women's Hospital Boston Massachusetts United States
この論文をさがす
説明
<jats:title>Abstract</jats:title><jats:p>Natriuretic peptide (NP) levels (B‐type natriuretic peptide (BNP) and N‐terminal proBNP) are now widely used in clinical practice and cardiovascular research throughout the world and have been incorporated into most national and international cardiovascular guidelines for heart failure. The role of NP levels in state‐of‐the‐art clinical practice is evolving rapidly. This paper reviews and highlights ten key messages to clinicians:</jats:p><jats:p><jats:list list-type="bullet"> <jats:list-item><jats:p>NP levels are quantitative plasma biomarkers of heart failure (HF).</jats:p></jats:list-item> <jats:list-item><jats:p>NP levels are accurate in the diagnosis of HF.</jats:p></jats:list-item> <jats:list-item><jats:p>NP levels may help risk stratify emergency department (ED) patients with regard to the need for hospital admission or direct ED discharge.</jats:p></jats:list-item> <jats:list-item><jats:p>NP levels help improve patient management and reduce total treatment costs in patients with acute dyspnoea.</jats:p></jats:list-item> <jats:list-item><jats:p>NP levels at the time of admission are powerful predictors of outcome in predicting death and re‐hospitalisation in HF patients.</jats:p></jats:list-item> <jats:list-item><jats:p>NP levels at discharge aid in risk stratification of the HF patient.</jats:p></jats:list-item> <jats:list-item><jats:p>NP‐guided therapy may improve morbidity and/or mortality in chronic HF.</jats:p></jats:list-item> <jats:list-item><jats:p>The combination of NP levels together with symptoms, signs and weight gain assists in the assessment of clinical decompensation in HF.</jats:p></jats:list-item> <jats:list-item><jats:p>NP levels can accelerate accurate diagnosis of heart failure presenting in primary care.</jats:p></jats:list-item> <jats:list-item><jats:p>NP levels may be helpful to screen for asymptomatic left ventricular dysfunction in high‐risk patients.</jats:p></jats:list-item> </jats:list></jats:p><jats:p>Published by Elsevier B.V. on behalf of European Society of Cardiology.</jats:p>
収録刊行物
-
- European Journal of Heart Failure
-
European Journal of Heart Failure 10 (9), 824-839, 2008-09
Wiley